Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Clinical trial NCT00491114 · COMPLETED

Trial details

NCT number: NCT00491114
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Neoplasms

Start date: 2003-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.